Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer

Brachytherapy

Volumn 5, Issue 4, 2006, Pages 223-229

  Datta, Niloy Ranjan ^a   Srivastava, Anurita ^a   Maria Das, Koilpillai Joseph ^a   Gupta, Archana ^a   Rastogi, Neeraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervix cancer; Image based brachytherapy; Intracavitary brachytherapy; Radiation dosimetry

Indexed keywords

ARTICLE; BLADDER; BRACHYTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; INTRACAVITY BRACHYTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RECTUM; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX CANCER;

BRACHYTHERAPY; FEMALE; HUMANS; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 33751055468     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2006.09.001     Document Type: Article

References (32)

1. ICRU Report no. 38. Dose and volume specification for reporting intracavitary therapy in gynecology (1985), International Commission on Radiation Units and Measurements, Bethesda, MD
2. Pötter R., Limbergen E.V., Gerstener N., et al. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 58 (2001) 11-18
3. Kim R.Y., and Pareek P. Radiography based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: Analysis of dose-volume histograms. Brachytherapy 2 (2003) 200-206
4. Meder-Haie C., Pötter R., Limbergen E.V., et al. Recommendations from Gynecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
5. Nag S., Cardenes H., Chang S., et al. Proposed guidelines from image based intracavitary brachytherapy for cervical carcinoma: Report from image guided brachytherapy-working group. Int J Radiat Oncol Biol Phys 60 (2004) 1160-1169
6. Schoeppel S.L., LaVigne M.L., Martel M.K., et al. Three dimensional treatment planning of intracavitary gynaecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 28 (1994) 277-283
7. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. The impact of sectional imaging on dose escalation in endocavitary brachytherapy of cervical cancer: Results of a prospective comparative trial. Radiother Oncol 68 (2003) 51-59
8. Walsh J.W., and Goplerud D.R. Prospective comparison between clinical and CT staging in primary cervical carcinoma. Am J Roentgenol 137 (1981) 997-1003
9. Datta N.R., Kumar S., Maria Das K.J., et al. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38. Radiother Oncol 60 (2001) 15-24
10. Hoskin P.J., Cook M., Bouscale D., et al. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy. Radiother Oncol 40 (1996) 59-62
11. King G.C., Bloomer W.D., Kalnicki S., et al. Point dose variations with time during traditional brachytherapy for cervical carcinoma. Med Dosim 25 (2000) 77-80
12. Lee C.M., Shrieve D.C., and Gaffney D.K. Rapid involution and mobility of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 58 (2004) 625-630
13. Wulf J., Popp K., Oppitz U., et al. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions. Strahlenther Onkol 180 (2004) 216-224
14. Datta N.R., Basu R., Das K.J.M., et al. Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix. Clin Oncol 16 (2004) 129-137
15. Elhanafy O.A., Das R.K., Paliwal B.R., et al. Anatomic variation of prescription points and treatment volume with fractionated high-dose-rate gynecological brachytherapy. J Appl Clin Med Phys 3 (2002) 1-5
16. Ito H., Kutuki S., Nishiguchi I., et al. Radiotherapy for cervical cancer with high dose rate brachytherapy-Correlation between tumour size, dose and failure. Radiother Oncol 31 (1994) 240-247
17. Katz A., and Eifel P.J. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48 (2000) 1417-1425
18. Petereit D.G., and Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule?. Int J Radiat Oncol Biol Phys 43 (1999) 359-366
19. Deore S.M., Viswanathan P.S., Shrivastava S.K., et al. Predictive role of TDF values in late rectal recto-sigmoid complications in irradiation treatment of cervix cancer. Int J Radiat Oncol Biol Phys 24 (1992) 217-221
20. Montana G.S., and Fowler W.C. Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 16 (1989) 95-100
21. Orton C.G., and Wolf-Rosenblum S. Dose dependence of complication rates in cervix cancer radiotherapy. Int J Radiat Oncol Biol Phys 12 (1986) 37-44
22. Perez C.A., Breaux S., Bedwinek J.M., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 54 (1984) 235-246
23. Perez C.A., Grisby P.W., Lockett M.A., et al. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 44 (1999) 855-866
24. Stryker J.A., Bartholomew M., Velkley D.E., et al. Bladder and rectal complications following radiotherapy for cervix cancer. Gynecol Oncol 29 (1988) 1-11
25. Yudelev M., Kuten K.A., Tatcher M., et al. Correlations of dose and time-dose-fractionation factors (TDF) with treatment results and side effects in cancer of the uterine cervix. Gynecol Oncol 23 (1986) 310-315
26. Hunter R.D., Wong F., Moore C., et al. Bladder base dosage in patients undergoing intracavitary therapy. Radiother Oncol 7 (1986) 189-197
27. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD and CT assisted techniques. Radiother Oncol 24 (1992) 137-146
28. Ling C.C., Schell M.C., Working K.R., et al. CT assisted assessment of bladder and rectum dose in gynaecological implants. Int J Radiat Oncol Biol Phys 13 (1987) 1577-1582
29. van Den Bergh F., Meertens H., Moonen L., et al. The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 47 (1998) 85-90
30. Pelloski C.E., Palmer M., Chronowski G.M., et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 131-137
31. Pötter R., Haie-Meder C., Limbergen E.V., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancers brachytherapy-3D Dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
32. Datta N.R. From 'points' to 'profiles' in intracavitary brachytherapy of cervical cancer. Curr Opin Obstet Gynecol 7 (2005) 35-41